Baihua Pharmaceutical hits 5th consecutive daily limit; innovative drug concept stocks remain active

U.S. court ruling on preliminary injunction shields WuXi AppTec from immediate effects of 1260H designation during judicial process.

Bio-Techne surged over 18% as part of the innovative drug concept stock rally.

Harbin Pharmaceutical Group hit its 2nd consecutive daily limit as innovative drug concept stocks remain active.

Baihua Pharmaceutical achieved its 5th consecutive daily limit, indicating strong investor interest in innovative drug concept.